These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4124059)

  • 1. Hormone therapy for malignant myeloma.
    Kiang DT; Theologides A; Fortuny I; Kennedy BJ
    Lancet; 1973 Jul; 2(7821):147-8. PubMed ID: 4124059
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis of myelomatosis on treatment with prednisone and cytostatics.
    Hansen OP; Jessen B; Videbaek A
    Scand J Haematol; 1973; 10(4):282-90. PubMed ID: 4764610
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208).
    Kyle RA; Seligman BR; Wallace HJ; Silver RT; Glidewell O; Holland JF
    Cancer Chemother Rep; 1975; 59(3):557-62. PubMed ID: 1203882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management of multiple myeloma.
    Korst DR
    Wis Med J; 1968 Nov; 67(11):566-8. PubMed ID: 5747569
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of multiple myeloma.
    Kyle RA; Maldonado JE; Bayrd ED
    Mayo Clin Proc; 1968 Oct; 43(10):730-7. PubMed ID: 5711940
    [No Abstract]   [Full Text] [Related]  

  • 6. Alkeran and multiple myeloma.
    Med Lett Drugs Ther; 1966 Apr; 8(8):32. PubMed ID: 5913764
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognosis in myelomatosis treated with prednisone and cytostatics].
    Hansen OP; Jessen B; Videbaek A
    Ugeskr Laeger; 1973 Jun; 135(23):1169-73. PubMed ID: 4757116
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of myeloma].
    Sonntag RW
    Dtsch Med Wochenschr; 1977 Sep; 102(36):1289-91. PubMed ID: 902591
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Kahler's disease].
    Foa J; Carcassonne Y
    Sem Hop; 1976 Jan; 52(3):165-71. PubMed ID: 186874
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of multiple myeloma.
    Ungaro P
    J Ky Med Assoc; 1973 Dec; 71(12):805-7. PubMed ID: 4766737
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rules of current therapy in multiple myeloma].
    Sonntag RW
    Schweiz Med Wochenschr; 1973 Sep; 103(38):1324-9. PubMed ID: 4763749
    [No Abstract]   [Full Text] [Related]  

  • 12. Report on the second myelomatosis trial after five years of follow-up. Medical Research Council's Working Party on Leukaemia in Adults.
    Br J Cancer; 1980 Dec; 42(6):813-22. PubMed ID: 7006663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of plasmacytoma].
    Gassel WD; Sodomann CP
    Ther Ggw; 1980 Sep; 119(9):980-1005. PubMed ID: 7466705
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.
    Bergsagel DE; Cowan DH; Hasselback R
    Can Med Assoc J; 1972 Nov; 107(9):851-5. PubMed ID: 4653931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined cytostatic therapy of plasmacytoma].
    Albert P; Zsuzsa M
    Orv Hetil; 1977 Jul; 118(31):1855-6. PubMed ID: 887257
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of multiple myeloma. Review of the recent trials].
    Tribalto M; Arcese W; Colombo R; Pastore S; Franchii A
    Recenti Prog Med; 1981 Aug; 71(2):141-7. PubMed ID: 7031807
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple myeloma. II. The value of melphalan.
    Bernard DB; Lynch SR; Bothwell TH; Bezwoda WR; Stevens K; Shulman G
    S Afr Med J; 1974 May; 48(24):1026-8. PubMed ID: 4835772
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent progress in chemotherapy of multiple myeloma].
    Tortarolo M; Cantore N; Russolillo S; Castaldo C; Buonanno G
    Recenti Prog Med; 1978 Jul; 65(1):44-68. PubMed ID: 370935
    [No Abstract]   [Full Text] [Related]  

  • 19. Vindesine therapy in melphalan-resistant multiple myeloma.
    Houwen B; Ockhuizen T; Marrink J; Nieweg HO
    Eur J Cancer (1965); 1981 Feb; 17(2):227-32. PubMed ID: 7262159
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal control analysis in the chemotherapy of IgG multiple myeloma.
    Swan GW; Vincent TL
    Bull Math Biol; 1977; 39(3):317-37. PubMed ID: 857983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.